Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study) E. Samuli Lepojärvi, MD, Olli-Pekka Piira, MD, Antti M. Kiviniemi, PhD, Johanna A. Miettinen, PhD, Tuomas Kenttä, PhD, Olavi Ukkola, MD, Mikko P. Tulppo, PhD, Heikki V. Huikuri, MD, M. Juhani Junttila, MD American Journal of Cardiology Volume 117, Issue 4, Pages 515-521 (February 2016) DOI: 10.1016/j.amjcard.2015.11.038 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 1 Kaplan–Meier primary end point–free survival curves for patients with a hs-TnT level ≥14 and <14 ng/l (A) and receiver operating characteristic curves for hs-TnT and predicted probabilities for the primary end point in analyzed multifactorial models (B) in the diabetic group. AUC = area under the curve; MACE = major adverse cardiac events. American Journal of Cardiology 2016 117, 515-521DOI: (10.1016/j.amjcard.2015.11.038) Copyright © 2016 Elsevier Inc. Terms and Conditions